CSMART study
20 December 2021
News Category: 

A group of researchers from the Royal Melbourne Hospital and Peter MacCallum Cancer Centre are investigating a nasal spray option to prevent respiratory viral infections, such as COVID-19 and the flu. 

With over 145 participants currently enrolled in the trial, the C-SMART study has been designed specifically for people diagnosed with cancer.

For more information on the study, please visit the C-SMART website: https://csmart.com.au/

Media Contact

For more information about this story, contact Communications on (03) 9342 7000 or email mh-communications@mh.org.au